(+)-MK 801Potent NMDA antagonist CAS# 70449-94-4 |
- (-)-MK 801
Catalog No.:BCC4593
CAS No.:121917-57-5
- Ro 25-6981 Maleate
Catalog No.:BCC4159
CAS No.:1312991-76-6
- SDZ 220-581
Catalog No.:BCC1939
CAS No.:174575-17-8
- SDZ 220-581 hydrochloride
Catalog No.:BCC4157
CAS No.:179411-93-9
- (+)-MK 801 Maleate
Catalog No.:BCC4014
CAS No.:77086-22-7
Quality Control & MSDS
Number of papers citing our products
Chemical structure
3D structure
| Cas No. | 70449-94-4 | SDF | Download SDF |
| PubChem ID | 1207 | Appearance | Powder |
| Formula | C16H15N | M.Wt | 221.30 |
| Type of Compound | N/A | Storage | Desiccate at -20°C |
| Solubility | >10.45mg/mL in DMSO | ||
| SMILES | CC12C3=CC=CC=C3CC(N1)C4=CC=CC=C24 | ||
| Standard InChIKey | LBOJYSIDWZQNJS-UHFFFAOYSA-N | ||
| Standard InChI | InChI=1S/C16H15N/c1-16-13-8-4-2-6-11(13)10-15(17-16)12-7-3-5-9-14(12)16/h2-9,15,17H,10H2,1H3 | ||
| General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
| About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
| Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. | ||
| Description | (+)-MK 801 is a potent antagonist of NMDA with Ki value of 30.5 nM. | |||||
| Targets | NMDA | |||||
| IC50 | 30.5 nM (Ki) | |||||
| Cell experiment: [1] | |
| Cell lines | Rat neocortical neurons |
| Preparation method | The solubility of this compound in DMSO is >10 mM. General tips for obtaining a higher concentration: Please warm the tube at 37 °C for 10 minutes and/or shake it in the ultrasonic bath for a while.Stock solution can be stored below -20°C for several months. |
| Reacting condition | 10 μM, 11 sec |
| Applications | Cell was held at -70 mV in the whole-cell recording mode, bathed in the Mg2+-free external solution. Application of 200 μM N-Me-D-Asp elicited an inward current that rose rapidly to a peak and then decayed to a steady current. When N-Me-D-Asp and 10 μM MK-801 were applied simultaneously, the current reached nearly the same peak but was then progressively blocked with a time constant of about 11 sec. The blockade by MK-801 persisted when the cell was washed with control solution for 20 sec. |
| Animal experiment: [2] | |
| Animal models | Male Wistar rats |
| Dosage form | Intrathecal injection, 20 μg |
| Application | The rats were given morphine (15 μg/h) for 5 days. On day 5 on which tolerance developed, at 3 h after discontinuation of morphine infusion, MK-801 was injected intrathecally 30 min before morphine challenge (15 μg). Pretreatment with MK-801 preserved its antinociceptive effect in morphine-tolerant rats in a dose-dependent manner, with amaximal effect at 60 min. The dose of 10 μg ofMK-801 resulted in only slight preservation of morphine-induced antinociception, while 5 μg of MK-801 had no effect. Injection of 20 μg of MK-801 significantly improved morphine-induced antinociception, with a maximal effect (MPE%) of up to 61%, with a 10 s tail-flick latency being defined as 100% MPE in saline-infused rats. |
| Other notes | Please test the solubility of all compounds indoor, and the actual solubility may slightly differ with the theoretical value. This is caused by an experimental system error and it is normal. |
| References: [1] Huettner J E, Bean B P. Block of N-methyl-D-aspartate-activated current by the anticonvulsant MK-801: selective binding to open channels. Proceedings of the National Academy of Sciences, 1988, 85(4): 1307-1311. [2] Liu C H, Cherng C H, Lin S L, et al. N-methyl-D-aspartate receptor antagonist MK-801 suppresses glial pro-inflammatory cytokine expression in morphine-tolerant rats. Pharmacology Biochemistry and Behavior, 2011, 99(3): 371-380. | |
(+)-MK 801 Dilution Calculator
(+)-MK 801 Molarity Calculator
| 1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
| 1 mM | 4.5188 mL | 22.5938 mL | 45.1875 mL | 90.3751 mL | 112.9688 mL |
| 5 mM | 0.9038 mL | 4.5188 mL | 9.0375 mL | 18.075 mL | 22.5938 mL |
| 10 mM | 0.4519 mL | 2.2594 mL | 4.5188 mL | 9.0375 mL | 11.2969 mL |
| 50 mM | 0.0904 mL | 0.4519 mL | 0.9038 mL | 1.8075 mL | 2.2594 mL |
| 100 mM | 0.0452 mL | 0.2259 mL | 0.4519 mL | 0.9038 mL | 1.1297 mL |
| * Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. | |||||
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
(+)-MK 801 is a potent antagonist of NMDA with Ki value of 30.5nM [1].
MK 801 is a potent anticonvulsant exhibits both anxiolytic and sympathomimetic properties. It is found to be a noncompetitive antagonist of NMDA. MK 801 can penetrate into the central nervous system. In the in vitro assay, MK 801 binds to rat cerebral cortical membrane with high affinity in a saturable manner. This binding is reversible even when the concentration of MK 801 is up to 100μM. It is also found that the binding shows a regional specificity. Most of these binding sites are located in the hippocampus. In rat cortical-slice preparations, MK 801 causes a potent blockade of depolarizing responses to NMDA with a high selectivity. This effect is persistent. The blockade can also cause a suppression of the epileptiform activity induced by tetrodotoxin or other neurotoxin [1].
References:
[1] Wong EH, Kemp JA, Priestley T, Knight AR, Woodruff GN, Iversen LL . The anticonvulsant MK-801 is a potent N-methyl-D-aspartate antagonist. Proc Natl Acad Sci U S A. 1986 Sep;83(18):7104-8.
- 17alpha-Neriifolin
Catalog No.:BCN4269
CAS No.:7044-31-7
- Dihydrotamarixetin
Catalog No.:BCN4268
CAS No.:70411-27-7
- 4(15),11-Oppositadien-1-ol
Catalog No.:BCN4267
CAS No.:70389-96-7
- Voleneol
Catalog No.:BCN4266
CAS No.:70389-88-7
- 6alpha-Hydroxynidorellol
Catalog No.:BCN4598
CAS No.:70387-38-1
- Lornoxicam
Catalog No.:BCC4425
CAS No.:70374-39-9
- Sideritoflavone
Catalog No.:BCN6689
CAS No.:70360-12-2
- Avobenzone
Catalog No.:BCC4891
CAS No.:70356-09-1
- Methyl Kakuol
Catalog No.:BCN8243
CAS No.:70342-29-9
- 3-Benzoylthiazolidine-2-thione
Catalog No.:BCC8624
CAS No.:70326-37-3
- Pertussis Toxin
Catalog No.:BCC7565
CAS No.:70323-44-3
- Fluoroorotic Acid, Ultra Pure
Catalog No.:BCC1209
CAS No.:703-95-7
- Pefloxacin
Catalog No.:BCC4231
CAS No.:70458-92-3
- Pefloxacin Mesylate
Catalog No.:BCC4821
CAS No.:70458-95-6
- Norfloxacin
Catalog No.:BCC4688
CAS No.:70458-96-7
- Corymbol
Catalog No.:BCN6617
CAS No.:7047-54-3
- Schizanthine A
Catalog No.:BCN1936
CAS No.:70474-24-7
- Petasinine
Catalog No.:BCN1988
CAS No.:70474-33-8
- Petasinoside
Catalog No.:BCN1989
CAS No.:70474-34-9
- Mitoxantrone HCl
Catalog No.:BCC4924
CAS No.:70476-82-3
- ARP 100
Catalog No.:BCC2370
CAS No.:704888-90-4
- 2'-Hydroxy-5'-methoxyacetophenone
Catalog No.:BCN4270
CAS No.:705-15-7
- 3,5-Dimethoxybenzylalcohol
Catalog No.:BCN3760
CAS No.:705-76-0
- α-Conotoxin PnIA
Catalog No.:BCC5978
CAS No.:705300-84-1
Cannabidiol Affects MK-801-Induced Changes in the PPI Learned Response of Capuchin Monkeys (Sapajus spp.).[Pubmed:28289391]
Front Pharmacol. 2017 Feb 27;8:93.
There are several lines of evidence indicating a possible therapeutic action of cannabidiol (CBD) in schizophrenia treatment. Studies with rodents have demonstrated that CBD reverses MK-801 effects in prepulse inhibition (PPI) disruption, which may indicate that CBD acts by improving sensorimotor gating deficits. In the present study, we investigated the effects of CBD on a PPI learned response of capuchin monkeys (Sapajus spp.). A total of seven monkeys were employed in this study. In Experiment 1, we evaluated the CBD (doses of 15, 30, 60 mg/kg, i.p.) effects on PPI. In Experiment 2, the effects of sub-chronic MK-801 (0.02 mg/kg, i.m.) on PPI were challenged by a CBD pre-treatment. No changes in PPI response were observed after CBD-alone administration. However, MK-801 increased the PPI response of our animals. CBD pre-treatment blocked the PPI increase induced by MK-801. Our findings suggest that CBD's reversal of the MK-801 effects on PPI is unlikely to stem from a direct involvement on sensorimotor mechanisms, but may possibly reflect its anxiolytic properties.
MK-801-Treated Oligodendrocytes as a Cellular Model to Study Schizophrenia.[Pubmed:28353246]
Adv Exp Med Biol. 2017;974:269-277.
Glutamate is the most important excitatory neurotransmitter in the brain. The N-methyl-D-aspartate (NMDA) subtype of glutamate receptor is found both in neurons and glial cells such as oligodendrocytes, which have been shown to be dysfunctional in schizophrenia. For this reasons, the oligodendrocyte MO3.13 cell line has been used to study glutamatergic dysfunction as a model of schizophrenia using the NMDA receptor antagonists such as MK-801 to block receptor function. Here, we describe a comprehensive protocol for culturing and carrying out proteomic analyses of MK-801-treated MO3.13 cells as a means of identifying potential new biomarkers and targets for drug discovery in schizophrenia research.
Permeation of Polymethoxyflavones into the Mouse Brain and Their Effect on MK-801-Induced Locomotive Hyperactivity.[Pubmed:28245567]
Int J Mol Sci. 2017 Feb 24;18(3). pii: ijms18030489.
Accumulating data have indicated that citrus polymethoxyflavones (PMFs) have the ability to affect brain function. In the present study, we showed that 3,5,6,7,8,3',4'-heptamethoxy- flavone (HMF) given intraperitoneally to mice was immediately detected in the brain and that the permeability of the brain tissues to it was significantly higher than that of other citrus PMFs (nobiletin, tangeretin, and natsudaidain). The permeation of these PMFs into the brain well correlated with their abilities to suppress MK-801-induced locomotive hyperactivity, suggesting that HMF had the ability to act directly in the brain. We also obtained data suggesting that the suppressive effect of HMF on MK-801-induced locomotive hyperactivity was mediated by phosphorylation of extracellular signal-regulated kinases 1/2 (ERK1/2) in the hippocampus.
